Kindred Healthcare Updates Strategy and Reports Third Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Stifel Downgrades Kindred Healthcare (KND) to Sell
November 8, 2016 7:03 AM ESTStifel downgraded Kindred Healthcare (NYSE: KND) from Hold to Sell with a price target of $5.00 (from $10.00).
For an analyst ratings summary and ratings history on Kindred Healthcare click here. For more ratings news on Kindred Healthcare click here.
Shares of Kindred Healthcare closed at $8.75 yesterday.
... MoreKindred Healthcare (KND) Misses Q3 EPS by 1c
November 7, 2016 4:48 PM ESTKindred Healthcare (NYSE: KND) reported Q3 EPS of $0.05, $0.01 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $1.79 billion versus the consensus estimate of $1.77 billion.
GUIDANCE:
Kindred Healthcare sees FY2016 EPS of $0.70-$0.80, versus the consensus of $0.90.... More
